Results 31 to 40 of about 60,453 (247)

Cystatin C Is Not Causally Related to Coronary Artery Disease. [PDF]

open access: yesPLoS ONE, 2015
Strong and independent associations between plasma concentration of cystatin C and risk of cardiovascular disease (CVD) suggests causal involvement of cystatin C.The aim of our study was to assess whether there is a causal relationship between plasma ...
Patrik Svensson-Färbom   +6 more
doaj   +1 more source

Cystatin C and lactoferrin concentrations in biological fluids as possible prognostic factors in eye tumor development [PDF]

open access: yes, 2013
Objectives. To investigate the possible role of cystatin C in eye biological fluids locally and in serum and lactoferrin revealing anti-tumor activity in eye tumor development. Background.
Ananthi S   +19 more
core   +1 more source

Cystatin C is Associated With Plaque Phenotype and Plaque Burden

open access: yesKidney & Blood Pressure Research, 2016
Background/Aims: The relationship between carotid artery plaque burden, phenotype and serum cystatin C at normal and impaired renal function is still unclear. Methods: Demographic characteristics, carotid ultrasonography and other relevant information of
Yufeng Wen   +9 more
doaj   +1 more source

Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis. [PDF]

open access: yesPLoS ONE, 2010
Amyotrophic lateral sclerosis (ALS) is a fatal neurologic disease characterized by progressive motor neuron degeneration. Clinical disease management is hindered by both a lengthy diagnostic process and the absence of effective treatments.
Meghan E Wilson   +3 more
doaj   +1 more source

Is cystatin C useful for the detection and the estimation of low glomerular filtration rate in heart transplant patients? [PDF]

open access: yes, 2007
Although previously studied in patients with chronic kidney disease, there is less data for the use of cystatin C and cystatin C-based formulas in heart transplant recipients.
Cavalier, Etienne   +8 more
core   +1 more source

Maternal Cystatin C Serum is Higher in Women with Severe Preeclampsia

open access: yesIndonesian Journal of Obstetrics and Gynecology, 2014
Objective: To determine the comparison between maternal cystatin C serum in severe preeclampsia and normal pregnancy. Method: This was an observational study with cross sectional analytic approach. The subjects are sixty women with severe preeclampsia
Kurnia M. Isasari   +3 more
doaj   +1 more source

Certification of Cystatin C in the Human Serum Reference Material ERM-DA471/IFCC - Certified Reference Material ERM®-DA471/IFCC [PDF]

open access: yes, 2010
The production of ERM-DA471/IFCC, certified for the mass concentration of cystatin C, is described. Serum was produced from blood collected in 2 collection centres according to a procedure ensuring that it was obtained from healthy donors, and that the ...
ALTHAUS Harald   +8 more
core   +1 more source

Estimation of glomerular filtration rate from serum creatinine and cystatin C in octogenarians and nonagenarians [PDF]

open access: yes, 2013
Background: Equations to estimate GFR have not been well validated in the elderly and may misclassify persons with chronic kidney disease (CKD). We measured GFR and compared the performance of the Modification of Diet in Renal Disease (MDRD), the Chronic
Araujo, Lara Q.   +6 more
core   +3 more sources

Cystatin C predicts cognitive decline in multiple system atrophy: A 1-year prospective cohort study

open access: yesFrontiers in Aging Neuroscience, 2022
BackgroundAccumulating evidence has suggested that cystatin C is associated with cognitive impairment in patients with neurodegenerative diseases. However, the association between cystatin C and cognitive decline in patients with multiple system atrophy (
Lingyu Zhang   +12 more
doaj   +1 more source

Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study [PDF]

open access: yes, 2018
Aims: To test the prognostic value of emerging biomarkers in the Reduction of Events by Darbepoetin Alfa in Heart Failure (RED-HF) trial. Methods and results: Circulating cardiac [N-terminal pro-B-type natriuretic peptide (NT-proBNP), and high ...
Alehagen   +34 more
core   +4 more sources

Home - About - Disclaimer - Privacy